Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

DGICB vs DCAP: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

DGICB Wins Head-to-Head Institutional Verdict (4–0 across 6 Pillars · 8–2 Matrix Metrics)

DGICB Overall Winner 6-Pillar Tally: DGICB 4 – 0 DCAP (2 Tie) Matrix Metrics: DGICB 8 – 2 DCAP

As of Nov 16, 2026, DGICB (DGICB) is the stronger overall head-to-head candidate over DCAP (DCAP) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 4–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). DGICB carries a Unified Composite Score of 30.8/100 (SELL) at $28.55 (14.4x Forward P/E, 9.0% operating margin), whereas DCAP carries 47.1/100 (HOLD) at $24.22 (N/M Forward P/E, N/A operating margin).

  • Composite vs. Pillar Nuance: While DCAP currently prints a higher short-term Unified Composite Score (47.1/100 HOLD vs. DGICB 30.8/100 SELL), DGICB captures the overall institutional head-to-head verdict (8–2 matrix metrics and 4–0 across the 6 pillars) due to superior fundamental profitability (9.0% vs. N/A operating margin) and revenue trajectory (-3.4% vs. N/A YoY).

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About DGICB vs DCAP
DGICB US Equity Head-to-Head Winner
DGICB
Institutional Equity
$28.55
+1.21% 1D
Market Cap $1.1B
TTM Revenue $955M
Forward P/E 14.4x
Beta / 30D Vol 0.27β · 86% Vol
Unified Composite Score
30.8 / 100 SELL
Tech 5.0 Fund 27.0 Flow 50.0 Mom 31.5
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (4.2% over 20 days), RSI 67
RSI-14: 66.6 · SMA20: $25.16 · SMA50: $21.89
DCAP US Equity
DCAP
Institutional Equity
$24.22
-0.87% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.22β · 9% Vol
Unified Composite Score
47.1 / 100 HOLD
Tech 50.0 Fund 50.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Trend telemetry aligned with daily close.
RSI-14: N/A · SMA20: N/A · SMA50: N/A

6-Pillar Scorecard Institutional Category Breakdown (DGICB 4 – 0 DCAP)

Columns: Metric · DGICB · DCAP
1. Valuation Multiples DGICB
Forward P/E 14.4x N/M
Trailing P/E 15.2x N/M
PEG Ratio 1.90x N/M
EV / Revenue 1.1x N/M
2. Growth & Scale DGICB
Revenue Growth (YoY) -3.4% N/A
Earnings Growth (YoY) -11.3% N/A
TTM Revenue (USD) $955M N/A
Market Cap $1.1B N/A
3. Profitability & Quality DGICB
Gross Margin 9.2% N/A
Operating Margin 9.0% N/A
Net Profit Margin 7.2% N/A
Return on Equity (ROE) 10.7% N/A
4. Balance Sheet & Cash Flow DGICB
Cash Generation (TTM) $88M EBITDA N/A
Cash Flow Margin 9.2% EBITDA Mgn N/A
Net Cash / Leverage $17.70 Book/Sh · 10.7% ROE N/A ROE
Dividend Yield 2.69% None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markup NEUTRAL · Neutral
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Insurance - Property & Casualty Operator Institutional Equity Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: DGICB (8) vs DCAP (2)
Institutional Metric DGICB DCAP Criterion Row Edge
Market Capitalization
Scale
$1.1B N/A Larger Scale DGICB
Trailing P/E Ratio
Valuation
15.2x N/M Lower Multiple DGICB
Forward P/E Ratio
Valuation
14.4x N/M Lower Multiple DGICB
Revenue Growth (YoY)
Growth
-3.4% N/A Higher Growth DGICB
Operating Margin (TTM)
Profitability
9.0% N/A Higher Margin DGICB
Net Profit Margin
Profitability
7.2% N/A Higher Margin DGICB
Return on Equity (ROE)
Capital Efficiency
10.7% N/A Higher ROE DGICB
52-Week Range Position
Momentum
91% ($14–$30) 0% ($24–$26) Stronger Trend DGICB
Beta / 30D Volatility
Risk Regime
0.27β · 86% Vol 0.22β · 9% Vol Lower Realized Risk DCAP
Unified Institutional Score
Composite Signal
30.8 / 100 (SELL) 47.1 / 100 (HOLD) Higher Composite DCAP
Trailing 12M Revenue (USD)
Operating Scale
$955M N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
9.2% N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
1.90x PEG · 1.1x EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$88M EBITDA ($17.70 Book/Sh · 10.7% ROE) N/A (N/A ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon DGICB +52.59 pp
DGICB: +49.09% · DCAP: -3.5%
3M Horizon DGICB +67.39 pp
DGICB: +63.99% · DCAP: -3.4%
6M Horizon DGICB +67.39 pp
DGICB: +63.99% · DCAP: -3.4%
1Y Horizon DGICB +67.39 pp
DGICB: +63.99% · DCAP: -3.4%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on DGICB vs DCAP. Trailing 12-month operating profitability (DGICB 9.0% vs DCAP N/A) and valuation multiples (DGICB 14.4x vs DCAP N/M Forward P/E) are benchmarked directly in Pillar 4 below.

DGICB ADR TTM Benchmark FX-Normalized USD
TTM Revenue$955M
Gross Margin9.2%
Op. Margin9.0%
ROE / Fwd P/E10.7% · 14.4x
DCAP ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
DGICB UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact DGICB Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
DCAP UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact DCAP Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
DGICB Moat Profile Cyclical / Execution-Driven Positioning
Insurance - Property & Casualty Operator
Competes within the Insurance - Property & Casualty value chain with $1.1B market capitalization and 9.0% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
DCAP Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ DGICB vs DCAP Key Questions & Quantitative Answers

As of Nov 16, 2026, DGICB (DGICB) is the stronger overall head-to-head candidate over DCAP (DCAP) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 4–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). DGICB carries a Unified Composite Score of 30.8/100 (SELL) at $28.55 (14.4x Forward P/E, 9.0% operating margin), whereas DCAP carries 47.1/100 (HOLD) at $24.22 (N/M Forward P/E, N/A operating margin). Composite vs. Pillar Nuance: While DCAP currently prints a higher short-term Unified Composite Score (47.1/100 HOLD vs. DGICB 30.8/100 SELL), DGICB captures the overall institutional head-to-head verdict (8–2 matrix metrics and 4–0 across the 6 pillars) due to superior fundamental profitability (9.0% vs. N/A operating margin) and revenue trajectory (-3.4% vs. N/A YoY).

DGICB leads the Growth & Scale pillar: DGICB posts -3.4% YoY revenue growth and -11.3% YoY earnings growth on $955M TTM revenue (9.2% gross margin, 9.0% operating margin), compared with DCAP at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, DGICB generates $955M in USD-normalized revenue versus N/A for DCAP. In operating R&D and SG&A reinvestment, DGICB deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for DCAP.

DGICB screens cheaper on headline valuation multiples. DGICB trades at 14.4x Forward P/E, 15.2x Trailing P/E, 1.90x PEG, and 1.1x EV/Revenue (9.2% EBITDA margin), whereas DCAP trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against DGICB (10.7% ROE) versus DCAP (N/A ROE) capital efficiency.

In options market volatility and institutional positioning, DGICB carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.27β · 86% Vol realized risk). By comparison, DCAP carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.22β · 9% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.